Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
To investigate the therapeutic effect of combined integrin α6β4-targeted radioimmunotherapy (RIT) and PI3K/mTOR inhibitor BEZ235 in a pancreatic cancer model.
Pubmed ID: 29204055
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Cell line BxPC-3 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions